Abbott Laboratories (ABT) Long-Term Debt Issuances (2010 - 2026)

Abbott Laboratories (ABT) has 10 years of Long-Term Debt Issuances data on file, last reported at $19.9 billion in Q1 2026.

• For the quarter ending Q1 2026, Long-Term Debt Issuances rose 1985900.0% year-over-year to $19.9 billion; the trailing twelve-month figure through Mar 2026 stood at $19.9 billion (up 8767.86% YoY), and the FY2025 full-year result was $5.0 million, down 97.76% from the prior year.
• Long-Term Debt Issuances improved to $19.9 billion in Q1 2026, from $2.0 million in the prior quarter.
• In the past five years, Long-Term Debt Issuances ranged from a high of $19.9 billion in Q1 2026 to a low of $1.0 million in Q3 2022.
• A 5-year average of $2.2 billion and a median of $1.0 million in 2022 frame the typical range for Long-Term Debt Issuances.
• Across the five-year window, Long-Term Debt Issuances tumbled 99.1% in 2025 and surged 1985900.0% in 2026, its largest moves.
• Tracing ABT's Long-Term Debt Issuances over 5 years: stood at $1.0 million in 2022, then changed by 0.0% to $1.0 million in 2023, then changed by 0.0% to $1.0 million in 2024, then surged by 100.0% to $2.0 million in 2025, then surged by 992900.0% to $19.9 billion in 2026.
• Business Quant data shows ABT's Long-Term Debt Issuances at $19.9 billion in Q1 2026, $2.0 million in Q4 2025, and $2.0 million in Q2 2025.